Healthcare has become the second-best performer in the S&P 500 (SP500) this month, prompting market observers to foresee a ...

Trump’s White House juggled a devastating American Airline flight-Black Hawk helicopter crash, a Chinese AI threat and looming tariffs just this week alone, making for a busy start to his four-year ...

FAA imposes helicopter restrictions near Reagan National Airport; U.S. readies for tariffs on imports from Mexico, Canada and ...

Zimmer Biomet Holdings, Inc. ZBH is scheduled to report fourth-quarter 2024 results on Feb. 6, before market open. See the ...

Swiss pharma giant Novartis AG NVS reported better-than-expected results for the fourth quarter of 2024. Core earnings (excluding one-time charges) of $1.98 per share easily beat the Zacks Consensus ...

The firm reported that its full-year 2024 revenues were up slightly as a rise in the diagnostics business was mostly offset by a decline in life sciences business.

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Liquidia Corporation's litigation battle and upcoming commercial launch of its primary candidate, YUTREPIA, take spotlight.

Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, Intel edges higher ...

Oil company Natural Resources and medical-device maker Beta Bionics shrug off a down market to gain in their trading debuts.

Currenc shares are trading higher on Wednesday after the company announced the launch of its SEAMLESS AI Call Center.

REUTERS/Brendan McDermid/File Photo U.S. stocks ended lower on Friday, with indexes losing ground after the White House said U.S. President Donald Trump will implement on Saturday tariffs of 25% ...